Clinical Trials
27 trialsCRITâ…ˇ
Sixth Affiliated Hospital, Sun Yat-sen University
FOBEAR
Sun Yat-sen University
A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer
Vaccinogen Inc
Neoadjuvant Treatment Modalities in Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
SURGIGAST
University Hospital, Lille
ETHOS
Norwegian Department of Health and Social Affairs
FOxTROT2France
Centre Hospitalier Universitaire Dijon
ESCC
Sichuan Cancer Hospital and Research Institute
FLOT5
Krankenhaus Nordwest
COLORII
Nova Scotia Health Authority
GRECCAR15
University Hospital, Bordeaux
CHIMERA
Jagiellonian University
Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)
Sun Yat-sen University
RCNAC
Fudan University
JCOG1801
National Cancer Center Hospital East
NEOPA
Universitätsklinikum Hamburg-Eppendorf
Clinical Analysis of HIPEC for T4 Colorectal Cancer After Surgery
Sixth Affiliated Hospital, Sun Yat-sen University
Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer
Sun Yat-sen University
Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer
Shanghai Chest Hospital
Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
Alliance for Clinical Trials in Oncology
Net-Pac
CHIR-Net
NEOPAC
Institut Paoli-Calmettes
EPIC-GC
Kyungpook National University Hospital
Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
Taiho Pharmaceutical Co., Ltd.
A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)
Taiho Pharmaceutical Co., Ltd.
A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)
Taiho Pharmaceutical Co., Ltd.
PHRAC
Fudan University